Vomizole

Indonesia • Dexa Medica

Indication

  • Duodenal ulcer
  • Gastric ulcer
  • Reflux esophagitis, moderate and severe cases of inflammation of the esophagus
  • Zollinger-Ellison syndrome

Composition

Pantoprazole 40 mg

Package

1 vial of 40 mg

Dosage Forms

Powder for Injection

ATC Classification

A02B

Warning

Alcohol
Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
Caution
This item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.
Pregnancy
Consult Your Doctor
Safety of this item for use during pregnancy has not been established. Please consult your doctor.
Lactation
Consult Your Doctor
Safety of this item for use during lactation has not been established. Please consult your doctor.

Dosage

0 to 18 Years Old

Safety and efficacy in children have not been established.

18 to 65 Years Old

The intravenous administration is recommended only if oral application is not appropriate.

Duodenal ulcer, gastric ulcer, reflux esophagitis:
The recommended intravenous dosage is one vial (40 mg pantoprazole) per day.

Zollinger-Ellison syndrome & other pathological hypersecretory conditions:
Patients should start their treatment with a daily dose of 80 mg pantoprazole IV. Thereafter, the dosage can be titrated up or down as needed using measurements of gastric acid secretion to guide. With doses above 80 mg daily, the dose should be divided and given twice daily. A temporary increase of the dosage above 160 mg pantoprazole is possible but should not be applied longer than required for adequate acid control. Transition from oral to IV and from IV to oral formulations of gastric acid inhibitors should be performed in such manner to ensure continuity of effect of suppression of acid secretion.

65 Years Old and Above

The daily dose of 40 mg pantoprazole should not be exceeded in elderly patients.

Patients with Impaired Renal Function

The daily dose of 40 mg pantoprazole should not be exceeded in patients with impaired renal function.

Patients with Severe Liver Impairment

In patients with severe liver impairment the daily dose has to be reduced to 20 mg pantoprazole. Furthermore, in these patients the liver enzymes should be monitored during pantoprazole IV therapy. In case of a rise of the liver enzymes pantoprazole IV should be discontinued.